PepVault › Peptides › CJC-1295 with DAC
CJC-1295 with DAC — dosage, half-life & reference guide
Growth hormone peptide · also known as CJC-1295 DAC, DAC:GRF
A long-acting growth hormone releasing hormone analogue. The DAC modification extends its half-life to nearly a week, meaning just one injection per week sustains elevated GH and IGF-1 levels. Convenient but creates continuous (non-pulsatile) GH elevation, which some consider less physiological.
Commonly-researched dose ranges
CJC-1295 with DAC is commonly researched at 1–2 mg, weekly, by SubQ injection. These are reference ranges from the literature and community use, not a prescription.
Half-life
Estimated half-life: 6–8 days (DAC extends half-life). See how it accumulates in the half-life calculator.
Safety & interactions
Commonly reported effects: water retention, headache, flushing, injection site pain, fatigue, carpal tunnel symptoms. Discuss with your clinician.
Open the full CJC-1295 with DAC guide (needs JavaScript). PepVault is a private research and tracking tool, not medical advice.